Annovis Bio (ANVS) Earnings Date & Reports

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANVS is expected to report earnings to fall 11.63% to -37 cents per share on May 08

Q1'25

Est.

$-0.38

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.46

Q2'24

Beat

by $0.19

Q1'24

Beat

by $0.10

The last earnings report on March 21 showed earnings per share of -43 cents, missing the estimate of -32 cents. With 351.52K shares outstanding, the current market capitalization sits at 32.15M.

View a ticker or compare two or three

Compare

ANVS